These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23357491)

  • 1. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome.
    Begtrup LM; Engsbro AL; Kjeldsen J; Larsen PV; Schaffalitzky de Muckadell O; Bytzer P; Jarbøl DE
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):956-62.e1. PubMed ID: 23357491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive diagnostic strategy is safe and saves endoscopies in patients with irritable bowel syndrome: A five-year follow-up of a randomized controlled trial.
    Engsbro AL; Begtrup LM; Haastrup P; Storsveen MM; Bytzer P; Kjeldsen J; Schaffalitzky De Muckadell O; Jarbøl DE
    Neurogastroenterol Motil; 2021 Mar; 33(3):e14004. PubMed ID: 33029843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life.
    García Carrasco M; Mendoza Pinto C; López Colombo A; Méndez Martínez S; Andari Sawaya R; Muñoz Guarneros M; Vázquez De Lara L; Lescas Hernández M; Montiel Jarquín A; Ramos Álvarez G; Schmulson M
    Neurogastroenterol Motil; 2013 Dec; 25(12):958-66. PubMed ID: 24112121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Rome III criteria is not likely to reduce the number of unnecessary referrals for colonoscopy in primary care.
    Kok L; Elias SG; Witteman BJ; Goedhard JG; Romberg-Camps MJ; Muris JW; Moons KG; de Wit NJ
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):568-74. PubMed ID: 23325277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
    Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.
    Spiegel BM; Gralnek IM; Bolus R; Chang L; Dulai GS; Mayer EA; Naliboff B
    Arch Intern Med; 2004 Sep; 164(16):1773-80. PubMed ID: 15364671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome - an evidence-based approach to diagnosis.
    Cash BD; Chey WD
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1235-45. PubMed ID: 15191504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease.
    Häuser W; Musial F; Caspary WF; Stein J; Stallmach A
    Psychosom Med; 2007 May; 69(4):370-6. PubMed ID: 17470666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Buono JL; Carson RT; Flores NM
    Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome in children with chronic gastrointestinal symptoms in primary care.
    Hogervorst EM; Ganzevoort IN; Berger MY; Holtman GA
    Fam Pract; 2024 Jun; 41(3):292-298. PubMed ID: 37392047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression.
    Afsar B; Elsurer R; Yilmaz MI; Eyileten T; Yenicesu M
    Nephrology (Carlton); 2010 Mar; 15(2):197-202. PubMed ID: 20470279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
    Guyonnet D; Chassany O; Ducrotte P; Picard C; Mouret M; Mercier CH; Matuchansky C
    Aliment Pharmacol Ther; 2007 Aug; 26(3):475-86. PubMed ID: 17635382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.